Timo Minssen (Former)
1 – 10 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Balancing innovation, 'ordre public' and morality in human germline editing : A call for more nuanced approaches in patent law
(2023) p.241-267
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
- Contribution to journal › Scientific review
-
Mark
Ecosystem effectuation : creating new value through open innovation during a pandemic
- Contribution to journal › Article
- 2021
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
(2021)
- Book/Report › Report
- 2020
-
Mark
Knowledge transfer for large scale vaccine manufacturing
- Contribution to journal › Article
-
Mark
Applying the Proportionality Principle to COVID-19 Antibody Testing
(2020) In Journal of Law and the Biosciences
- Contribution to journal › Article
-
Mark
AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities
(2020) p.239-268
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Book introduction: An Appraisal of the EU Directive on Trade Secrets
(2020) p.1-7
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The harmonization and protection of trade secrets in the EU: – An Appraisal of the EU Directive
(2020)
- Book/Report › Book
-
Mark
When does stand-alone software qualify as a medical device in the European Union?: The CJEU decision in SNITEM and what it implies for the next generation of medical devices
- Contribution to journal › Article
